Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.! 京ICP备19006400号-1 Powered by 300.cn
美科
Links:
Stemedica mesenchymal stem cells were approved and listed by Ministry of Health of Kazakhstan as a treatment of acute myocardial infarction.
Source:
Release time:
2018/09/12 16:32
Page view
用Stemedica干细胞治疗急性心梗获得哈萨克斯坦卫生部批准上市。